ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CINGW Cingulate Inc

0,0218
0,0002 (0,93%)
10 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Cingulate Inc CINGW NASDAQ Equity Warrant
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,0002 0,93% 0,0218 17:00:02
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,0218 0,0218 0,0218 0,0218 0,0216
mais cotações »

Notícias Recentes

Data Hora Fonte Título
08/05/202408:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
30/04/202406:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/04/202418:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/04/202409:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/03/202417:45GLOBECingulate to Participate in Benzinga All Live Access Event
06/03/202408:45GLOBECingulate to Attend DCAT Week 2024 in New York City
13/02/202408:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
06/02/202418:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
02/02/202411:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29/01/202410:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/01/202408:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
01/12/202311:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
13/11/202318:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
17/10/202315:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
21/09/202314:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
13/09/202317:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
11/09/202310:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
11/09/202307:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
08/09/202317:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
05/09/202309:00GLOBECingulate Announces Presentation of Full Trial Results from..
14/08/202317:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
11/07/202309:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
29/06/202309:00GLOBECingulate Successfully Manufactures Clinical Supply –..
14/06/202316:45GLOBECingulate to Participate in the Healthcare Virtual..
08/06/202308:00GLOBECingulate Completes Phase 3 Adult Trial of CTx-1301..
25/05/202316:55GLOBECingulate to Present at 13th Annual LD Micro Invitational